Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer’s Disease

So far, there is no effective disease-modifying therapies for Alzheimer’s Disease (AD) in clinical practice. In this context, glycine-L-proline-L-glutamate (GPE) and its analogs may open the way for developing a novel molecule for treating neurodegenerative disorders, including AD. In turn, this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Turkez, Hasan, Cacciatore, Ivana, Marinelli, Lisa, Fornasari, Erika, Aslan, Mehmet Enes, Cadirci, Kenan, Kahraman, Cigdem Yuce, Caglar, Ozge, Tatar, Abdulgani, Di Biase, Giuseppe, Hacimuftuoglu, Ahmet, Di Stefano, Antonio, Mardinoglu, Adil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835747/
https://www.ncbi.nlm.nih.gov/pubmed/33478054
http://dx.doi.org/10.3390/biom11010126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835747/
https://www.ncbi.nlm.nih.gov/pubmed/33478054
http://dx.doi.org/10.3390/biom11010126

Ejemplares similares